← Back to Search

Lung Preservation System

OCS Lung Preservation for Lung Transplant

N/A
Waitlist Available
Research Sponsored by TransMedics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male or female primary double lung transplant candidate
Age ≥ 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 72 hours post-transplant
Awards & highlights

Study Summary

This trial is testing a new system to treat lungs that are not healthy enough to be transplanted. The goal is to see if this system can make these lungs healthy enough to be transplanted.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days post-transplantation or initial hospital discharge post-transplantation, a mean of 41.5 days post-transplant
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days post-transplantation or initial hospital discharge post-transplantation, a mean of 41.5 days post-transplant for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Donor Lung Utilization Rate
Patient Survival
Secondary outcome measures
Primary Graft Dysfunction Grade 3
Other outcome measures
Number of Lung Graft-related Serious Adverse Events

Trial Design

1Treatment groups
Experimental Treatment
Group I: OCS PreservationExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
OCS Lung Preservation
2013
N/A
~80

Find a Location

Who is running the clinical trial?

TransMedicsLead Sponsor
22 Previous Clinical Trials
18,525 Total Patients Enrolled
1 Trials studying Lung Transplant
79 Patients Enrolled for Lung Transplant

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
OCS Lung System EXPAND II Trial
2018. "OCS Lung System EXPAND II Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03343535.
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top